Ontology highlight
ABSTRACT:
SUBMITTER: Caroli J
PROVIDER: S-EPMC7056894 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
Caroli Jimmy J Dori Martina M Bicciato Silvio S
Frontiers in oncology 20200227
Since the pioneering NCI-60 panel of the late'80's, several major screenings of genetic profiling and drug testing in cancer cell lines have been conducted to investigate how genetic backgrounds and transcriptional patterns shape cancer's response to therapy and to identify disease-specific genes associated with drug response. Historically, pharmacogenomics screenings have been largely heterogeneous in terms of investigated cell lines, assay technologies, number of compounds, type and quality of ...[more]